ArticleFrontiers in immunology2025

B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China.

Yili Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.